bioRxivMicrobiology
Rapid and consistent evolution of colistin resistance in Pseudomonas aeruginosa during morbidostat culture
B. Regenbogen, M. Willmann, M. Steglich, B. Bunk, U. Nubel, S. Peter, R. A. Neher
Abstract
Colistin is a last resort antibiotic commonly used against multidrug-resistant strains of Pseudomonas aeruginosa. To investigate the potential for in-situ evolution of resistance against colistin and map the molecular targets of colistin resistance, we exposed two P. aeruginosa isolates to colistin using a continuous culture device known as morbidostat. Colistin resistance emerged within two weeks along with highly stereotypic yet strain specific mutation patterns. The majority of mutations hit the prmAB two component signaling system and genes involved in lipopolysaccharide synthesis, including lpxC, pmrE, and migA. In seven out of 18 cultures, we observed mutations in mutS along with a mutator phenotype that seemed to facilitate resistance evolution.
- organism: bacteria (other)
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Localized hypermutation drives the evolution of unstable colistin resistance in small populations of Pseudomonas aeruginosa
N. Kapel, J. F. Diaz Caballero, C. MacLean·bioRxiv·Aug 10, 2021
- Fitness trade-off and the discovery of a novel missense mutation in the PmrB sensor kinase of a colistin-resistant Pseudomonas aeruginosa strain developed by adaptive laboratory evolution
Indira Padhy, Sambit Kumar Dwibedy, Saswat Sourav Mohapatra·Microbial PathogenesisPeer-reviewed·Mar 12, 2025
- Using population-level whole-genome sequencing to profile colistin resistance evolution dynamics in diverse clinical Pseudomonas aeruginosa lineages
Kellie R. Strickland, Miriana L. Littlejohn, … Derek S. Sarovich·bioRxiv·Sep 24, 2026
- Resistance, heteroresistance and fitness costs drive colistin treatment failure during Acinetobacter baumannii murine pneumonia
Juan Hernandez-Bird, Bixi He, … Ralph R. Isberg·Proceedings of the National Academy of SciencesPeer-reviewed·Dec 29, 2025
- Mutations in pmrB confer cross-resistance to the LptD inhibitor POL7080 and colistin in Pseudomonas aeruginosa
K. P. Romano, T. Warrier, … D. T. Hung·bioRxiv·Mar 8, 2019
- Colistin heteroresistance and the involvement of the PmrAB regulatory system in Acinetobacter baumannii
Y. Charretier, S. M. Diene, … J. Schrenzel·bioRxiv·Apr 25, 2018